Related Experiment Video
Updated: Oct 5, 2025
08:05
Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
14.4K
Chylothorax found in a patient with COVID-19
Francesco Satriano1, Giulia Scioscia2, Maria Grazia Cagnazzo1
1Respiratory Unit Covid2 Pneumologia 2 Covid - DEA "V. Fazzi" Hospital Lecce Italy.
Respirology Case Reports
|January 31, 2022
Summary
This case study highlights chylothorax as a rare complication of COVID-19. Researchers confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in a patient who developed chylothorax and thrombosis.
Area of Science:
- Medicine
- Infectious Diseases
- Pulmonology
Background:
- Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, presents with a wide range of clinical severity.
- Pleural effusion is a known, though less common, manifestation of COVID-19.
Observation:
- A 78-year-old male with confirmed SARS-CoV-2 infection presented with dyspnea, cough, and asthenia.
- Imaging revealed right pleural effusion, which was drained via thoracentesis and identified as chylothorax.
- Further imaging demonstrated mediastinal and venous thrombosis.
Findings:
- Chylothorax was diagnosed in a patient with COVID-19.
- The patient also exhibited partial thrombosis of the superior vena cava and right subclavian vein.
- Anticoagulant therapy led to clinical and radiological improvement.
Implications:
- This case suggests chylothorax is a potential, albeit uncommon, complication of COVID-19.
- The findings underscore the importance of considering thrombotic events in severe COVID-19 cases.
- Further research may elucidate the mechanisms linking SARS-CoV-2 infection to chylothorax and thrombosis.
Related Concept Videos
01:27Pneumothorax-II
436
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
436
01:26Pneumothorax-I
581
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
581
01:26Endoscopic Studies II: Thoracocentesis
607
Thoracentesis(Thoracocentesis), commonly known as pleural tap, is a medical procedure where a 22 gauge needle is inserted into the pleural space, the area between the lung and chest wall. This procedure is commonly performed to diagnose or treat various respiratory disorders.
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
607
01:28Pleural Effusion II: Symptoms and Management
312
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
312
01:24Flail Chest-I
324
Overview of Flail Chest
Flail chest is a severe and potentially life-threatening condition characterized by the fracture of three or more adjacent ribs in multiple places. It is most commonly caused by direct impacts and trauma, such as motor vehicle accidents or injuries from a steering wheel impact. It can also occur due to falls in elderly individuals with osteoporosis, or assaults involving sharp objects.
Pathophysiology
The pathophysiology of flail chest is complex, involving fractures of...
Flail chest is a severe and potentially life-threatening condition characterized by the fracture of three or more adjacent ribs in multiple places. It is most commonly caused by direct impacts and trauma, such as motor vehicle accidents or injuries from a steering wheel impact. It can also occur due to falls in elderly individuals with osteoporosis, or assaults involving sharp objects.
Pathophysiology
The pathophysiology of flail chest is complex, involving fractures of...
324
01:24Chest Physiotherapy
863
Chest Physiotherapy (CPT) is a therapeutic technique used in respiratory care to improve ventilation, clear bronchial secretions, and enhance the efficiency of respiratory muscles. This therapy includes three primary procedures: postural drainage, percussion, and vibration. It can be performed on spontaneously breathing patients and those who are intubated and mechanically ventilated.
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
863